HAVN Life Sciences Inc.
HAVN
Rank in Stocks
#38568
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and... HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
Share Price
$0.02201811
Last synced: 2024-07-23
Market Cap
$847.02K
Change (1 day)
-0.22%
Change (1 year)
21,918.11%
Country
CA
Trade HAVN Life Sciences Inc. (HAVN)
Category
Healthcare
Stock price history for HAVN Life Sciences Inc. (HAVN)
Highest end of day price: $0.00 on 2026-10-01
Lowest end of day price: $20.74 on 2020-10-01
Lowest end of day price: $20.74 on 2020-10-01
Stock price history of HAVN Life Sciences Inc. from 2020 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -78.42% |
| 2024 | -84.57% |
| 2023 | -46.81% |
| 2022 | -98.79% |
| 2021 | -81.70% |
| 2020 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
